Danaher Corporation

Danaher’s pricing power stems from mission‑critical consumables and validated workflows where reagent or component changes can trigger revalidation and regulatory work, making price the secondary driver to reliability and time‑to‑market.

Bioprocessing resins, single‑use assemblies and chromatography hardware command premium pricing due to performance, quality and supply assurance. Cepheid’s decentralized molecular tests benefit from convenience and speed with sticky cartridge pull‑through.

While the company has executed targeted price increases, parts of Life Sciences consumables and academic markets remain price sensitive and funding constrained, tempering absolute pricing headroom. Net: solid pricing power in core consumables with room for mix upgrade as new premium assays, resins and instruments ramp.